| Title |
A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial
|
|---|---|
| Published in |
Trials, October 2020
|
| DOI | 10.1186/s13063-020-04746-9 |
| Pubmed ID | |
| Authors |
Shin Takayama, Takao Namiki, Takashi Ito, Ryutaro Arita, Hajime Nakae, Seiichi Kobayashi, Tetsuhiro Yoshino, Tomoaki Ishigami, Koichiro Tanaka, Mosaburo Kainuma, Kotaro Nochioka, Airi Takagi, Masaru Mimura, Takuhiro Yamaguchi, Tadashi Ishii |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 5 | 21% |
| United States | 2 | 8% |
| Singapore | 1 | 4% |
| United Kingdom | 1 | 4% |
| Unknown | 15 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 92% |
| Practitioners (doctors, other healthcare professionals) | 1 | 4% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 182 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 182 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 21 | 12% |
| Student > Master | 19 | 10% |
| Other | 17 | 9% |
| Researcher | 17 | 9% |
| Lecturer | 13 | 7% |
| Other | 34 | 19% |
| Unknown | 61 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 25% |
| Nursing and Health Professions | 22 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Psychology | 8 | 4% |
| Biochemistry, Genetics and Molecular Biology | 6 | 3% |
| Other | 23 | 13% |
| Unknown | 69 | 38% |